PBH

MKT CAP:$3B

Prestige Consumer Healthcare Inc.

Market Cap

$3B

Healthcare·Medical - Distribution·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$57.77-$3.45 (-5.64%)

Apr 23, 2026

Company Details

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operat...

CEO

William C. P'Pool

IPO Date

Feb 10, 2005

Website

www.prestigebrands.com

Key Metrics TTM

Revenue

$1.1B

-1.3% YoY

Net Income

$187M

EPS (Diluted)

$3.78

Free Cash Flow

$267M

Revenue / Share

$22.96

Gross Margin

56.4%

Operating Margin

29.2%

Net Margin

16.9%

FCF Margin

24.2%

P/S

2.6x

P/E

15.1x

Earnings Reports

Q4 2026

May 14, 2026

PENDING

Q3 2026

Feb 5, 2026

$283M-2.4%EPS $0.97

Q2 2026

Nov 6, 2025

$274M-3.3%EPS $0.86

Q1 2026

Aug 7, 2025

$250M-6.6%EPS $0.95

FY 2025

May 9, 2025

$1.1B+1.1%EPS $4.29

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 22	$267M	$149M	$77M
Q1 23	$277M	$160M	$87M
Q2 23	$289M	$161M	$84M
Q3 23	$276M	$150M	$87M
Q4 23	$286M	$154M	-$281M
Q1 24	$279M	$155M	$85M
Q2 24	$286M	$160M	$88M
Q3 24	$283M	$158M	$87M
Q4 24	$277M	$152M	$82M
Q1 25	$267M	$146M	$72M
Q2 25	$284M	$157M	$84M
Q3 25	$290M	$161M	$92M
Q4 25	$297M	$176M	$88M
Q1 26	$250M	$135M	$72M
Q2 26	$274M	$154M	$80M
Q3 26	$283M	$157M	$82M

Valuation

Quarter	P/S	P/E
Q4 22	2.6x	13.7x
Q1 23	2.6x	13.9x
Q2 23	2.5x	13.5x
Q3 23	2.5x	13.4x
Q4 23	2.5x	—
Q1 24	2.5x	—
Q2 24	2.5x	—
Q3 24	2.5x	—
Q4 24	2.5x	13.5x
Q1 25	2.5x	13.8x
Q2 25	2.5x	13.7x
Q3 25	2.5x	13.2x
Q4 25	2.5x	13.1x
Q1 26	2.5x	13.2x
Q2 26	2.5x	14.1x
Q3 26	2.6x	15.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	$63M	$60M
Q1 23	$58M	$57M
Q2 23	$58M	$55M
Q3 23	$55M	$53M
Q4 23	$59M	$56M
Q1 24	$48M	$47M
Q2 24	$62M	$60M
Q3 24	$71M	$69M
Q4 24	$67M	$64M
Q1 25	$55M	$54M
Q2 25	$70M	$68M
Q3 25	$65M	$64M
Q4 25	$62M	$58M
Q1 26	$79M	$78M
Q2 26	$57M	$55M
Q3 26	$78M	$75M

Capital Expenditures

Quarter	CapEx
Q4 22	$3M
Q1 23	$1M
Q2 23	$2M
Q3 23	$2M
Q4 23	$3M
Q1 24	$1M
Q2 24	$3M
Q3 24	$2M
Q4 24	$3M
Q1 25	$1M
Q2 25	$2M
Q3 25	$2M
Q4 25	$3M
Q1 26	$838.0K
Q2 26	$2M
Q3 26	$3M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+12.3%	+13.6%
Q1 23	+2.9%	+6.9%
Q2 23	+4.7%	+3.7%
Q3 23	+0.4%	-1.8%
Q4 23	+7.1%	+199.1%
Q1 24	+0.8%	+2.1%
Q2 24	-1.0%	-3.3%
Q3 24	+2.6%	+4.0%
Q4 24	-3.1%	-65.6%
Q1 25	-4.4%	+0.5%
Q2 25	-1.0%	+0.6%
Q3 25	+2.7%	+1.2%
Q4 25	+7.1%	+6.9%
Q1 26	-6.6%	-8.9%
Q2 26	-3.3%	-2.4%
Q3 26	-2.4%	+1.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$2M	0.6%
Q1 23	$4M	1.4%
Q2 23	$3M	1.2%
Q3 23	$2M	0.9%
Q4 23	$3M	0.9%
Q1 24	$4M	1.5%
Q2 24	$4M	1.3%
Q3 24	$2M	0.9%
Q4 24	$4M	1.3%
Q1 25	$3M	1.3%
Q2 25	$2M	0.8%
Q3 25	$3M	1.0%
Q4 25	$3M	0.9%
Q1 26	$4M	1.5%
Q2 26	$2M	0.6%
Q3 26	$3M	1.0%

OpEx Breakdown

Quarter	G&A	S&M
Q4 22	$28M	$37M
Q1 23	$27M	$40M
Q2 23	$26M	$44M
Q3 23	$27M	$30M
Q4 23	$28M	$31M
Q1 24	$28M	$36M
Q2 24	$26M	$40M
Q3 24	$26M	$39M
Q4 24	$26M	$38M
Q1 25	$29M	$39M
Q2 25	$26M	$41M
Q3 25	$26M	$38M
Q4 25	$27M	$37M
Q1 26	$28M	$35M
Q2 26	$28M	$39M
Q3 26	$30M	$40M

Revenue Segments

Quarter	Analgesics	Cough and Cold	Dermatologicals	Eye and Ear Care	Gastrointestinal	Oral Care	Other OTC	Women's Health
Q4 22	$25M	$28M	$28M	$44M	$54M	$22M	$3M	$63M
Q1 23	$28M	$28M	$30M	$43M	$54M	$24M	$3M	$66M
Q2 23	$33M	$31M	$34M	$43M	$57M	$24M	$3M	$64M
Q3 23	$30M	$38M	$28M	$38M	$57M	$24M	$3M	$58M
Q4 23	$28M	$30M	$31M	$47M	$58M	$25M	$3M	$63M
Q1 24	$28M	$26M	$36M	$43M	$58M	$25M	$3M	$60M
Q2 24	$31M	$33M	$34M	$47M	$53M	$23M	$3M	$62M
Q3 24	$30M	$33M	$28M	$45M	$62M	$23M	$3M	$58M
Q4 24	$28M	$26M	$31M	$44M	$60M	$25M	$3M	$60M
Q1 25	$28M	$21M	$33M	$48M	$58M	$21M	$3M	$55M
Q2 25	$28M	$29M	$36M	$43M	$60M	$24M	$3M	$60M
Q3 25	$31M	$29M	$31M	$46M	$69M	$23M	$3M	$58M
Q4 25	$30M	$27M	$29M	$47M	$69M	$27M	$4M	$64M
Q1 26	$29M	$19M	$30M	$32M	$58M	$22M	$3M	$57M
Q2 26	$29M	$27M	$36M	$34M	$64M	$25M	$3M	$56M
Q3 26	$28M	$29M	$30M	$39M	$69M	$27M	$4M	$58M

Revenue by Geography

Quarter	Non-US	United States
Q4 22	$47M	$220M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$27M	$0	$27M
Q1 23	$36M	$0	$36M
Q2 23	$42M	$0	$42M
Q3 23	$86M	$0	$86M
Q4 23	$58M	$0	$58M
Q1 24	$55M	$0	$55M
Q2 24	$60M	$0	$60M
Q3 24	$64M	$0	$64M
Q4 24	$46M	$0	$46M
Q1 25	$34M	$0	$34M
Q2 25	$52M	$0	$52M
Q3 25	$51M	$0	$51M
Q4 25	$98M	$0	$98M
Q1 26	$140M	$0	$140M
Q2 26	$119M	$0	$119M
Q3 26	$62M	$0	$62M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 22	51M	+0.1%	+0.9%
Q1 23	51M	-0.5%	+0.1%
Q2 23	50M	-0.9%	-1.0%
Q3 23	50M	-0.2%	-1.5%
Q4 23	50M	-0.8%	-2.3%
Q1 24	50M	+0.8%	-1.1%
Q2 24	50M	-0.2%	-0.4%
Q3 24	50M	+0.1%	-0.1%
Q4 24	50M	+0.4%	+1.0%
Q1 25	50M	-0.1%	+0.1%
Q2 25	50M	-0.5%	-0.2%
Q3 25	50M	-0.0%	-0.3%
Q4 25	50M	+0.2%	-0.5%
Q1 26	50M	-0.5%	-0.9%
Q2 26	49M	-1.1%	-1.5%
Q3 26	48M	-2.4%	-3.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 22	$498.9K	535
Q1 23	$517.9K	535
Q2 23	$540.7K	535
Q3 23	$515.0K	535
Q4 23	$510.5K	560
Q1 24	$498.8K	560
Q2 24	$511.3K	560
Q3 24	$504.9K	560
Q4 24	$485.9K	570
Q1 25	$468.7K	570
Q2 25	$497.5K	570
Q3 25	$509.3K	570
Q4 25	$494.6K	600
Q1 26	$415.9K	600
Q2 26	$456.9K	600
Q3 26	$472.4K	600

Revenue / Employee